tradingkey.logo

Evotec SE

EVO
3.530USD
+0.010+0.28%
終値 02/06, 16:00ET15分遅れの株価
1.25B時価総額
損失額直近12ヶ月PER

Evotec SE

3.530
+0.010+0.28%

詳細情報 Evotec SE 企業名

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SEの企業情報

企業コードEVO
会社名Evotec SE
上場日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)
従業員数4827
証券種類Depository Receipt
決算期末Oct 11
本社所在地Essener Bogen 7
都市HAMBURG
証券取引所NASDAQ OMX - NASDAQ BASIC
Germany
郵便番号22419
電話番号4940560810
ウェブサイトhttps://www.evotec.com/
企業コードEVO
上場日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)

Evotec SEの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2024
FY2023
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
他の
37.16M
4.31%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Fri, Feb 6
更新時刻: Fri, Feb 6
株主統計
種類
株主統計
株主統計
比率
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
他の
97.52%
株主統計
株主統計
比率
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
他の
97.52%
種類
株主統計
比率
Sovereign Wealth Fund
1.29%
Investment Advisor
0.93%
Investment Advisor/Hedge Fund
0.42%
Family Office
0.05%
Hedge Fund
0.04%
Research Firm
0.01%
他の
97.25%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
76
9.39M
2.97%
--
2025Q3
77
9.39M
2.97%
-16.64K
2025Q2
74
9.40M
2.85%
+334.04K
2025Q1
60
9.08M
2.82%
-923.30K
2024Q4
59
8.93M
2.90%
+634.42K
2024Q3
56
8.37M
3.36%
+770.57K
2024Q2
55
7.62M
2.73%
+2.19M
2024Q1
54
5.00M
2.98%
-5.56M
2023Q4
57
5.71M
1.76%
+4.47M
2023Q3
51
1.23M
1.80%
-162.10K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Sep 30, 2025
Wellington Management Company, LLP
1.43M
0.4%
+224.34K
+18.61%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.27M
0.36%
-42.77K
-3.25%
Sep 30, 2025
DCF Advisers, LLC
1.20M
0.34%
+84.50K
+7.58%
Sep 30, 2025
WCM Investment Management
300.28K
0.08%
+2.37K
+0.80%
Sep 30, 2025
Parametric Portfolio Associates LLC
224.96K
0.06%
-78.54K
-25.88%
Sep 30, 2025
Pitcairn
161.77K
0.05%
-99.41K
-38.06%
Sep 30, 2025
Citadel Advisors LLC
96.05K
0.03%
+62.47K
+186.07%
Sep 30, 2025
LPL Financial LLC
75.66K
0.02%
+37.82K
+99.92%
Sep 30, 2025
Envestnet Asset Management, Inc.
75.71K
0.02%
-15.95K
-17.40%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Biotechnology ETF
0.08%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
比率0.08%
ActivePassive International Equity ETF
比率0%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI